iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

ISIN IE00BDZVHG35

 | 

Ticker BTEE

TER
0,35% p.a.
Distribution policy
Distribution
Replication
Physique
Fund size
EUR 69 m
Inception Date
5 mars 2018
Holdings
246
 

Overview

Trade this ETF at your broker

Choose your broker
Advertisement
InvestEngineXtrackersBack the AI boom. AI’s reshaping markets. Tired of watching? Invest with Xtrackers. Capital at risk. Find out more
In paid partnership.

Description

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
 
The ETF's TER (total expense ratio) amounts to 0,35% p.a.. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is the cheapest ETF that tracks the Nasdaq Biotechnology index. The ETF replicates the performance of the underlying index by sampling technique (buying a selection of the most relevant index constituents). The dividends in the ETF are distributed to the investors (Halfjaarlijks).
 
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a small ETF with 57m GBP assets under management. The ETF was launched on 5 March 2018 and is domiciled in Ierland.
Show more Show less

Chart

Basics

Data

Investment approach Long-only
Index
Nasdaq Biotechnology
Investment focus
Aandelen, Verenigde Staten, Gezondheidszorg
Fund size
EUR 69 m
Total expense ratio
0,35% p.a.
Replication Physical (Optimized sampling)
Legal structure ETF
Sustainability No
Fund currency USD
Currency hedged No
Inception/ Listing Date 5 maart 2018
Distribution policy Distributing
Distribution frequency Semi annually
Fund domicile Ierland
Fund Provider iShares

Tax status

Germany 30% belastingvermindering
Switzerland ESTV Reporting
Austria Belastingrapportagefonds
UK UK-rapportage
Italy 26,0%
Indextype Total return index
Swap counterparty -
Collateral manager Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank
Securities lending Yes
Securities lending counterparty Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
Similar ETFs via ETF search
Advertisement
JPMorgan
JPM Equity Premium Income Active ETFs
Upgrade your income.
Explore
Capital at risk
How do you like our ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

Top 10 Holdings

Weight of top 10 holdings
out of 246
45,35%
Gilead Sciences, Inc.
8,15%
Amgen, Inc.
7,83%
Vertex Pharmaceuticals
7,67%
Moderna, Inc.
5,03%
Regeneron Pharmaceuticals, Inc.
5,02%
Revolution Medicines
2,88%
Illumina, Inc.
2,70%
Biogen
2,18%
Alnylam Pharmaceuticals
2,16%
Roivant Sciences Ltd.
1,73%

Countries

Verenigde Staten
88,54%
Verenigd Koninkrijk
2,36%
Nederland
2,15%
Ierland
1,56%
Anders
5,39%
Show more

Sectors

Gezondheidszorg
99,79%
Niet-energetische materialen
0,01%
Anders
0,21%
Show more
As of 30/09/2026

ETF Savings plan offers

Hier vind je informatie over de beschikbaarheid van het beleggingsplan van de ETF. Je kunt de tabel gebruiken om alle beleggingsplanaanbiedingen voor de geselecteerde spaarrente te vergelijken.
 
Broker Rating Execution fee Account fee
0,00 €
0,00 €
Voir l'offre**
0,00 €
0,00 €
Voir l'offre*
0,00 €
0,00 €
Voir l'offre*
Source : Recherche justETF; Statut : 11/2026. Les offres sont triées comme suit: 1. Évaluation 2. Commission par plan d’épargne 3. Nombre de plans d'épargne d’ETF. Des frais supplémentaires peuvent s'ajouter aux frais indiqués par les brokers en ligne. Les frais mentionnés sont donc majorés des spreads habituels du marché, des frais d'entrée, des coûts des produits et des coûts externes. A noter : Nous ne pouvons garantir l'exhaustivité, l'exactitude et la précision du contenu de la liste. Les informations de référence sont celles que l'on trouve sur les sites web des courtiers en ligne. Investir comporte des risques.
* Lien d'affiliation
** Remarque importante : Nous faisons partie du groupe Scalable depuis 2021 et sommes une filiale détenue à 100 % par Scalable AG. Cela signifie que nous sommes liés économiquement, tout en opérant en toute indépendance éditoriale. Les conflits d’intérêts sont évités, car les courtiers — y compris Scalable — sont évalués selon des critères uniformes et objectifs. Vous pouvez les consulter dans notre système de notation transparent. En fin de compte, c’est à vous de décider comment et avec qui vous souhaitez investir.

Performance

De rendementscijfers zijn inclusief uitkeringen/dividenden (als die er zijn). Standaard wordt het totale rendement van de ETF weergegeven.

Returns overview

YTD +31.32%
1 month +5.01%
3 months +5.98%
6 months +29.66%
1 year +31.87%
3 years +84.03%
5 years +52.99%
Since inception (MAX) +129.08%
2025 +17.31%
2024 +5.34%
2023 +0.76%
2022 -5.13%

Monthly returns in a heat map

Dividends

Current dividend yield

Huidig dividendrendement 0,20%
Dividends (last 12 months) EUR 0,02

Historic dividend yields

Period Dividend in EUR Dividend yield in %
1 jaar EUR 0,02 0,27%
2025 EUR 0,03 0,44%
2024 EUR 0,03 0,47%
2023 EUR 0,02 0,40%
2022 EUR 0,03 0,42%

Dividend yield contribution

Monthly dividends

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Risk indicator
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
Lower risk Higher risk
Volatility 1 year 22.69%
Volatility 3 years 21.65%
Volatility 5 years 22.94%
Return per risk 1 year 1.40
Return per risk 3 years 1.04
Return per risk 5 years 0.39
Maximum drawdown 1 year -7.03%
Maximum drawdown 3 years -25.58%
Maximum drawdown 5 years -25.58%
Maximum drawdown since inception -31.04%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR OM3E -
-
-
-
-
London Stock Exchange USD BTEE BTEE LN
INAVBTDU
BTTE.L

Frequently asked questions

What is the name of BTEE?

The name of BTEE is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

What is the ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The primary ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is BTEE.

What is the ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is IE00BDZVHG35.

What are the costs of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The total expense ratio (TER) of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) amounts to 0,35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) paying dividends?

Yes, iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is paying dividends. Usually, the dividend payments take place halfjaarlijks for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

What's the fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is 57m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.